Jobs / United States / Gilead Sciences INC
Senior Director Marketing, HIV Treatment Portfolio Strategy
Gilead Sciences INC · 🇺🇸 United States - California - Foster City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles1 certified filing for “Sr Director, Commercial Product Strategy” (Marketing Managers) in CA: $272k–$272k, median $272k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description Senior Director, HIV Treatment Portfolio Strategy The Senior Director, HIV Treatment Portfolio Strategy is responsible for defining and advancing the integrated portfolio strategy across Gilead's HIV Treatment brands. As the portfolio expands to include multiple complementary brands, this leader ensures brand strategies, investments, and commercial approaches work together intentionally to maximize long-term patient impact, portfolio value, and franchise growth while preserving clear brand-level ownership and accountability. This role serves as the enterprise integrator for the HIV Treatment business, partnering closely with Brand Leadership, Sales, Medical Affairs, Market Access, Insights & Analytics, Finance, Commercial Operations, and Global teams to identify portfolio opportunities, establish strategic priorities, guide investment and resource allocation decisions, and enable coordinated decision-making across brands. The role is accountable for portfolio direction, governance, prioritization, and strategic integration, while brand and capability leaders translate those priorities into specialized strategies, activation plans, and business outcomes. The Senior Director identifies and frames the portfolio's most consequential strategic choices, evaluates opportunities, risks, dependencies, and trade-offs across brands, and develops objective recommendations that enable timely executive decisions and coordinated organizational action. This includes assessing growth opportunities, competitive responses, investment trade-offs, and future priorities. Key Responsibilities The Senior Director, Portfolio Strategy is accountable for defining the integrated HIV Treatment portfolio strategy, establishing portfolio priorities, leading cross-brand decision-making, and optimizing investment and resource allocation across the business. The role does not own brand, customer engagement, media, digital, field, or channel strategies. Instead, it establishes the portfolio direction, priorities, governance, and decision frameworks that guide those functions. Brand teams and portfolio capability leaders translate portfolio priorities into specialized strategies, execution plans, and measurable business outcomes. Portfolio Strategy, Growth & Investment Prioritization • Lead the development and alignment of the integrated HIV Treatment Portfolio Strategy, defining the role of each brand and how brands work together to address evolving patient, customer, and market needs. • Own the portfolio planning framework, connecting long-range strategy, annual planning, investment decisions, and busin